Form 3 Filing for Chase LoPriore - Hepion Pharmaceuticals, Inc.

This filing reports initial beneficial ownership of Hepion Pharmaceuticals, Inc. (HEPA) common stock by Chase LoPriore. Following the transaction, Mr. LoPriore directly owns 1,250,000 shares of common stock. The report was filed on May 26, 2026, reflecting changes as of March 16, 2026. Mr. LoPriore is identified as a director of the company.